Clinical Trial Update: A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip Replacement [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the stability and long-term performance of the C-Stem AMT hip stem in total hip replacement has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Nonunion of Femoral Fractures
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Slipped Capital Femoral Epiphysis
• Traumatic Femoral Fractures

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED